Add Yahoo as a preferred source to see more of our stories on Google. A medical breakthrough is showing promise for Americans with Type 1 diabetes. It's an alternative for taking insulin without the ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

Ecnoglutide, a novel once-weekly injection for type 2 diabetes management, works as well as dulaglutide (a commonly prescribed once-a-week injection to manage diabetes) in lowering blood sugar levels, ...